CDT logo

CDT EQUITY INC

CDTNASDAQ
πŸ† #4370 by market capUS Equity
$2.96β–Ό $0.14 (βˆ’4.82%)
Market closed Β· at close
1hβ€”
24hβ–Ό 4.8%
7dβ–Ό 17.3%
14dβ–² 1.0%
30dβ–Ό 21.1%
1yβ–Ό 99.9%
🏦Market Cap
$1M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+0.0%
Slowing
πŸ“ŠGross Margin
38.6%
Healthy
πŸ’΅FCF Margin
-0.1%
Thin
βš–οΈP/S Ratio
0.0x
Cheap
Otter Score
62
Fair

Trading Snapshot

Day Range
$2.92 – $3.00
52-Week Range
$2.53 – $3,700.00
Volume
$5.02B
Avg Volume
$5.90B
Shares Outstanding
485,835
Next Earnings
Sep 28, 2026

Fundamentals Snapshot

Annual Revenue
$1.45B
Last Q Revenue
$750M
P/E Ratio
0.0
P/S Ratio
0.0x
EPS (TTM)
$2.34
Dividend Yield
0.00%

Why Investors Own CDT

  • βœ“High-growth profile β€” revenue up +39.7% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 29% gross margin and 19% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.45Bβ–² +39.5% YoY
Gross Margin (TTM)
29.4%β–² +0.8% YoY
Operating Income (TTM)
$334Mβ–² +39.5% YoY
Free Cash Flow (TTM)
$272Mβ–² +39.5% YoY

About CDT EQUITY INC

Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
62/100

Analyst Price Target

β“˜
Average Target
$3.13
β–² +5.9% Upside
High Target$3.50
Low Target$2.85
Based on 15 analysts

Latest News & Updates